CD8B and diffuse large B-cell lymphoma: According to our cell viability test, WZ811 suppressed the cell viability of both ABC-DLBCL (OCI-Ly3) and GCB-DLBCL (SU-DHL4), which confirmed the results of our bioinformatics analysis (Figure 5).